logo

Johnson & Johnson (JNJ)



Trade JNJ now with
  Date
  Headline
6/4/2020 10:33:35 AM Janssen:EU Oks DARZALEX Subcutaneous Formulation For Currently Approved Daratumumab Intravenous Formulation Indications
5/29/2020 9:21:40 AM J&J Gets Positive CHMP Opinion For Janssen's Investigational Preventive Ebola Vaccine Regimen
4/14/2020 6:32:49 AM Johnson & Johnson (JNJ) Declares Quarterly Dividend of $ 1.01, Record Date 5/26/2020
4/14/2020 6:32:48 AM Johnson & Johnson Q1 EPS Of $2.17 Increases 56.1%; Adj. EPS Of $2.30 Increases 9.5%
4/14/2020 6:32:17 AM Johnson & Johnson Declares 6.3% Increase In Quarterly Dividend To $1.01 Per Share
3/30/2020 7:27:30 AM Johnson & Johnson Announces A Lead Vaccine Candidate For COVID-19